Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2019 · 10-Q
Revenue$174.51M$174.51M+13.2% vs Q2 2018 Net Income$17.56M$17.56M−64.1% vs Q2 2018 EPS Diluted$0.45$0.45−65.1% vs Q2 2018 Gross Profit$113,018,000+11.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$46,563,000+18.8% Free Cash Flowderived$41,959,000+27.7% Margins · derivedGross margin64.8%−1.3 pt vs Q2 2018
Operating margin19.3%+3.6 pt vs Q2 2018
Net margin10.1%−21.6 pt vs Q2 2018
ended Dec 31, 2018 · filed Feb 7, 2019 · 38 d after period end